2 Volatile Healthcare Stocks

Vital Therapies is laying off 85 employees after halting development of its liver treatment

Sep 14, 2018 at 9:50 AM
facebook twitter linkedin


Shortly before yesterday's close, STAAR Surgical Company (NASDAQ:STAA) said the Food and Drug Administration (FDA) had approved the implantable eye lens maker's Visian Toric ICL lens to correct blurred vision caused by myopia. STAA stock surged 4.1% as a result, and is extending this upside today after a brokerage firm chimed in on the decision.

Canaccord Genuity reiterated its "buy" rating and boosted its price target to $55 from $43, saying Thursday's approval "represents tangible progress for the company along the path of tapping into the large U.S. market opportunity," and the Nov. 1 launch of the product will likely create a catalyst for the firm to raise current guidance. At last check, STAA shares are up 2% to trade at $551.75, and just hit a new record high of $54 out of the gate.

This positive price action has likely caught a number of short sellers off guard. Short interest jumped almost 37% in the latest reporting period to 1.17 million shares -- the most since mid-March. This could create bigger tailwinds for STAA stock, should some of the weaker bearish hands capitulate to its upside momentum.

On the flip side is Vital Therapies Inc (NASDAQ:VTL). VTL stock was last seen down 18.7% at $0.40, matching its record low share price hit this past Wednesday, Sept. 12. While devastating drug data sent the security down nearly 93% two days ago, today's drop comes on the heels of a round of company layoffs. Specifically, Vital Therapies said it has terminated 85 employees after suspending the development of its treatment for liver disease, which will result in a severance cost of $2 million to $2.5 million.

 

  

These investors are using the market's volatility to their advantage and scoring triple-digit gains on many of their trades.

Even in today's sideways bear market, this trading strategy has continued to provide consistency and profitability to a small group of investors. By using this approach, these traders are removing directional risk and still hitting triple-digit returns. If you want access to this strategy, and lower risk with higher returns sounds good to you, then don't wait another minute.

Join us now to receive our next trades the moment they come out!

 

Common mistakes options traders make
 


 


 
Special Offers from Schaeffer's Trading Partners